Media
Femasys in the
Femasys in the
conversation.
Podcasts, press coverage, educational videos, webinars, blog posts, and press resources — everything you need to stay current on Femasys and our women’s health innovations.
Featured
News
August 2026
Femasys Secures $30 Million Private Placement, with Potential Proceeds of Up to $90 Million
Feb 22, 2023
The Post-Roe Fertility Journey
SXSW
Read ↗
Jan 9, 2023
US biomedical company launches intrauterine device for tubal evaluation
FemTech World
Read ↗
Nov 15, 2022
Femasys Announces Commercial Availability of FemCath
Femasys IR
Read ↗
Nov 3, 2022
Femasys Targets Male Infertility with Updated Trial Design
BioWorld
Read ↗
Oct 20, 2022
Femasys Inc. Provides Strategic Update on its FemaSeed Pivotal Trial Design to Expedite Clinical Program Advancement
Femasys IR
Read ↗
Oct 12, 2022
Femasys Inc. Announces the Appointment of Christine Thomas as Senior Vice President of Regulatory and Clinical Affairs
GlobeNewswire
Read ↗
Stay Current
Women’s health news, delivered.
Get the latest Femasys updates — from progress on FemaSeed® fertility commercialization and the FemBloc® U.S. clinical trial to educational events and press releases — delivered directly to your inbox.
You can unsubscribe from these communications at any time.
For more information on our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.